Class action lawsuit filed against Marinus Pharmaceuticals, Inc. (MRNS) – filing deadline is August 5, 2024

NEW YORK, July 9, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Marinus Pharmaceuticals, Inc. (“Marinus” or the “Company”) (NASDAQ: MRNS) in a securities class action lawsuit.

CLASS DEFINITION: The aim of the lawsuit is to recover losses on behalf of Marinus investors caused by allegedly Securities Fraud between 17 March 2021 And May 7, 2024. Follow the link below for more information and to be contacted by a member of our team:

Marinus Lawsuit Submission Form

MRNS Investors can also Joseph E. Levi, Esq. per email to (email protected) or by phone at (212) 363-7500.

CASE DETAILS: The complaint filed claims that Defendants made false statements and/or failed to disclose that: (1) Defendants downplayed the risk of failure to meet the criteria for early termination of the Randomized Therapy in Status Epilepticus (RAISE) trial; (2) Defendants failed to disclose that a potential consequence of failure to meet the criteria for early termination of the RAISE trial would be that Marinus would terminate the separate Phase 3 RAISE II trial; and (3) as a result, Defendants’ statements about their business, operations and prospects were materially false and misleading and/or at no time had a reasonable basis.

WHAT’S NEXT? If you have suffered a loss with Marinus during the relevant period, you have until 5 August 2024 to request that the Court appoint you as lead plaintiff. Your ability to share in any compensation is not dependent on your serving as lead plaintiff.

NO COST TO YOU: If you are a member of a class action lawsuit, you may be entitled to compensation without incurring any out-of-pocket costs or fees. Participation is free of charge and involves no obligations.

WHY LEVI & KORSINSKY: Over the past 20 years, the Levi & Korsinsky team has recovered hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive experience representing investors in complex securities litigation and a team of over 70 people dedicated to serving our clients. For seven consecutive years, Levi & Korsinsky has been recognized as one of the leading securities litigation firms in the ISS Securities Class Action Services Top 50 Report. The United States.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 17th Floor
New York, NY 10004
(email protected)
Phone: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

Never miss a story from Levi & Korsinsky, LLP again.